Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials

Autor: Marczyk, M., Mrukwa, A., Yau, C., Wolf, D., Chen, Y.-Y., Balassanian, R., Nanda, R., Parker, B.A., Krings, G., Sattar, H., Zeck, J.C., Albain, K.S., Boughey, J.C., Liu, M.C., Elias, A.D., Clark, A.S., Venters, S.J., Shad, S., Basu, A., Asare, S.M., Buxton, M., Asare, A.L., Rugo, H.S., Perlmutter, J., DeMichele, A.M., Yee, D., Berry, D.A., Veer, L. van’t, Symmans, W.F., Esserman, L., Pusztai, L.
Zdroj: In Annals of Oncology August 2022 33(8):814-823
Databáze: ScienceDirect